Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension

by Naga P Bhavanam, Athena eFailla, Young eCho, Richard F. Lockey, Narasaiah eKolliputi
Published 2015-10-01